HOME >> MEDICINE >> NEWS
MRI superior to ultrasound in predicting cerebral palsy in preterm infants

In a comparison study between MRI and ultrasound for predicting cerebral palsy in very low birth weight (VLBW) infants, researchers from Stanford University Medical Center in Palo Alto, CA, found that MRI is superior to ultrasound in both sensitivity and positive predictive value for cerebral palsy, whereas both ultrasound and MRI showed relatively high specificity and negative predictive value.

Based on the results of the study, the authors recommend that ultrasound screening be performed for all VLBW infants, including at near-term. If ultrasound is predictive of cerebral palsy, then MRI may not be needed. If ultrasound is not predictive of cerebral palsy, MRI with diffusion tensor imaging should be performed. Pat Barnes, MD, one of the authors of the study, explained, "Since ultrasound is more readily available (including its portability in the intensive care setting) and less expensive, it is used first. If it shows findings predictive of cerebral palsy, then there is probably no need for MRI. If conventional MRI is needed, then diffusion tensor imaging is done at that time and would be important to do especially if the conventional MRI is negative or nonspecific."

According to the authors, other indications could also influence the choice of imaging technique used. "For managing the acutely ill preterm newborn, especially for intraventricular hemorrhage and posthemorrhagic hydrocephalus, ultrasound is indicated. If there are other or additional concerns (for example, white matter injury), then MRI with diffusion tensor imaging is clearly superior," said Dr. Barnes.

The researchers are currently investigating the role of MR spectroscopy in predicting cerebral palsy in VLBW infants. According to Dr. Barnes, "We are now just collecting that data. The potential is that MR spectroscopy may detect metabolic changes when no macrostructural changes (by ultrasound or conventional MRI) or microstructural changes (by diffusion tensor imaging) are
'"/>

Contact: Jason Ocker
jason@arrs.org
703-858-4304
American Roentgen Ray Society
3-May-2004


Page: 1 2

Related medicine news :

1. Kinder, gentler procedure gives superior results for stem cell transplants
2. Therapy, medication combination superior for children with obsessive-compulsive disorder
3. Universit de Montral study shows superior sound-location skills in the blind
4. CellCept(R) registry data demonstrated superior long-term organ transplant outcomes
5. Wavefront LASIK demonstrated superior to conventional LASIK
6. Transvaginal ultrasound superior to transrectal ultrasound for staging rectal cancer in women
7. Mycophenolate mofetil superior to azathioprine: Slows vascular disease progression after transplant
8. Linezolid is superior treatment for drug-resistant pneumonia
9. PET scans superior in revealing response to treatment for gastrointestinal stromal tumors
10. Endovascular coil superior to neurosurgery for treatment of brain haemorrhage
11. Secret agents secret revealed - shaken martinis have superior antioxidant properties to those that are stirred

Post Your Comments:
(Date:10/22/2014)... 2014 On Saturday, October 25, 2014, the ... family health and fitness fair ¡Vive tu vida! Get Up! ... good nutrition for better health and wellness for people of ... and open to the public, will be held at Dean ... am to 1:00 pm. , “¡Vive tu Vida! Get ...
(Date:10/22/2014)... 2014 Isabel Healthcare will ... Professions (ASAHP) Conference on October 22-24 in Las Vegas, ... in a panel discussion on Technology in Health Professions ... provides a diagnostic decision support tool and clinical education ... of students and clinical learners. The Isabel tools help ...
(Date:10/22/2014)... (HealthDay News) -- The United States is now ... nations of West Africa land at one of ... with the virus. In a statement released ... 94 percent of air passengers from Guinea, Liberia ... these five airports -- New York City,s Kennedy ...
(Date:10/22/2014)... California (PRWEB) October 22, 2014 Hay House ... Move Beyond Addiction and Upgrade Your Life (Paperback; $10.82) written ... of Yoga & Recovery. This book is meant to ... in a life of recovery. , Recovery 2.0 is ... 12 Steps; Recovery 2.0 is a guide for what comes ...
(Date:10/22/2014)... 22, 2014 Best Cheap Hosting USA ... world. The site has recently announced that iPower ( ... for people from around the world. , “iPower is ... today and is providing various kinds of useful products ... insists on offering excellent customer service and a number ...
Breaking Medicine News(10 mins):Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 2Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 3Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 4Health News:Isabel Healthcare to Participate in The Association of Schools of Allied Health Professions (ASAHP) 2014 Conference 2Health News:Passengers From Ebola-Affected Countries Must Land at Designated U.S. Airports 2Health News:Passengers From Ebola-Affected Countries Must Land at Designated U.S. Airports 3Health News:Hay House Announces The Official Release of Recovery 2.0: Move Beyond Addiction and Upgrade Your Life 2Health News:Hay House Announces The Official Release of Recovery 2.0: Move Beyond Addiction and Upgrade Your Life 3Health News:Best Cheap Hosting USA Has Recently Announced The Best Cheap Web Hosting Companies In 2014 2
(Date:10/22/2014)... , Oct. 22, 2014 WHEN: Wednesday, October ... complimentary registration available at: http://bit.ly/1yStiU9 ... Vidyasekar and Visionary Innovation Research Group Senior ... electricity, self-assembling materials, nanobots and flexible electronics ... will transform our lives in the coming ...
(Date:10/22/2014)... , Oct. 22, 2014  Regulus ... a biopharmaceutical company leading the discovery and ... announced that it has demonstrated human proof-of-concept ... clinical study evaluating RG-101, a wholly-owned, GalNac-conjugated ... of hepatitis C virus infection ("HCV").  Interim ...
(Date:10/20/2014)... , Oct. 20, 2014  Luoxis Diagnostics, ... MKT: AMPE), today announced that its academic collaborators ... and research potential for its novel RedoxSYS Diagnostic ... (ORP) in the body in response to injury ... of ORP as a clinical marker will be ...
Breaking Medicine Technology:Futuristic Technologies That Will Transform Our World Beyond 2030 2Futuristic Technologies That Will Transform Our World Beyond 2030 3Futuristic Technologies That Will Transform Our World Beyond 2030 4A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 2A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 3A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 4A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 5A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 6A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 7A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 8Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 2Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 3Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 4Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 5
Cached News: